CN108339039B

CN108339039B - Chinese medicine for treating bone injury

Info

Publication number: CN108339039B
Application number: CN201810520195.0A
Authority: CN
Inventors: 郑方; 郑华; 郑伟晴; 韩德生
Original assignee: Individual
Current assignee: Individual
Priority date: 2018-05-28
Filing date: 2018-05-28
Publication date: 2021-04-02
Anticipated expiration: 2038-05-28
Also published as: CN108339039A

Abstract

The invention discloses a traditional Chinese medicine for treating bone injury, which consists of the following traditional Chinese medicines in parts by weight: 10-20 parts of dipsacus root, 5-15 parts of ground beetle, 5-15 parts of roasted nux vomica, 10-20 parts of myrrh, 15-25 parts of safflower, 5-15 parts of dragon's blood, 5-12 parts of cinnabar, 15-25 parts of rhubarb and 25-35 parts of cortex acanthopanacis. The invention has the advantages that: the medicine has reasonable compatibility, and has the functions of detumescence, stasis removal, blood circulation promotion, pain relief, reunion of fractured bones, hemostasis, pain relief and new tissue regeneration; the traditional Chinese medicine is mainly products of liver and kidney, supplements each other in the aspects of promoting blood circulation, enhancing tissue metabolism and strengthening fracture healing, has obvious efficacy, is suitable for closed fracture and comminuted fracture of various parts of the whole body, can obtain ideal curative effect without operation, and has obvious curative effect on osteoarthritis such as neck, shoulder, waist, leg, rheumatic ostealgia, traumatic injury and the like.

Description

Chinese medicine for treating bone injury

Technical Field

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine for treating bone injuries.

Background

Fracture refers to the interruption of continuity or disruption of integrity of the trabecular bone, and fracture healing is a complex process of aggregation of multiple repair cells and genes. Fractures are often found in children and the elderly, and sometimes occur in middle-aged people. The patients usually have one part fracture and a few are multiple fractures, most patients can recover the original functions through timely and proper treatment, and the few patients can have sequelae with different degrees. The traditional Chinese medicine considers that fracture healing is a process of removing blood stasis, promoting tissue regeneration and osteosynthesis, theories of' removing blood stasis and setting bone are developed, most of the traditional Chinese medicines with the effects of promoting blood circulation, removing blood stasis or tonifying are selected during clinical treatment of fracture, and patients with bone injury diseases such as neck, shoulder, waist, leg, arthralgia, rheumatism, rheumatoid disease and the like increase year by year to become common diseases and frequently encountered diseases of people. The existing methods for treating the bone injury mainly comprise surgical treatment, physical therapy, western medicine treatment and traditional Chinese medicine treatment, but the surgical treatment cost is high, the pain of patients is increased, new hyperplasia is easy to form, the physical therapy is suitable for patients with mild disease conditions, the pain of the patients can be temporarily relieved, radical treatment is difficult, the western medicine treatment price is high, side effects are caused, and the existing traditional Chinese medicine for treating the bone injury is long in treatment course, slow in effect taking and not very obvious in curative effect and is not easy to accept by people.

Disclosure of Invention

The invention aims to provide the traditional Chinese medicine for treating the bone injury, which has the advantages of quick response, short treatment period, exact curative effect, difficult relapse after healing and relatively low cost.

The technical scheme adopted by the invention is as follows: a traditional Chinese medicine for treating bone injury comprises the following traditional Chinese medicines in parts by weight: 10-20 parts of dipsacus root, 5-15 parts of ground beetle, 5-15 parts of roasted nux vomica, 10-20 parts of myrrh, 15-25 parts of safflower, 5-15 parts of dragon's blood, 5-12 parts of cinnabar, 15-25 parts of rhubarb and 25-35 parts of cortex acanthopanacis.

The traditional Chinese medicine for treating bone injury comprises the following optimized components in parts by weight: 15 parts of dipsacus root, 10 parts of ground beetle, 10 parts of processed nux vomica, 15 parts of myrrh, 20 parts of safflower, 10 parts of dragon's blood, 10 parts of cinnabar, 20 parts of rhubarb and 30 parts of cortex acanthopanacis.

In the formula: radix Dipsaci, bitter and pungent in flavor, slightly warm, entering liver and kidney meridians, and its effects are nourishing liver and kidney, strengthening tendons and bones, regulating blood vessels, continuing fracture, promoting blood circulation and removing blood stasis as monarch drug; the ground beetles are salty and cold in taste, have small toxicity, enter liver channels, break blood stasis and continue bones and muscles; roasted nux vomica, which is bitter and cold in taste and has great toxicity, enters liver and spleen channels, and is used for dissipating stagnation, reducing swelling, removing blood stasis and relieving pain; the myrrh is pungent, bitter and mild in flavor, has the effects of entering heart, liver and spleen channels, activating blood circulation to stop pain, and clearing swelling and promoting granulation; safflower is pungent and warm in flavor, enters heart and liver meridians, promotes blood circulation, removes meridian obstruction, removes stasis, relieves pain, and promotes blood circulation; the dragon's blood is sweet, salty and flat in taste, enters liver meridian, promotes blood circulation, relieves pain, removes blood stasis, stops bleeding and promotes tissue regeneration, and the medicines are ministerial medicines; the cinnabar is sweet and slightly cold in taste and toxic, enters heart channels, soothes nerves and relieves palpitation, clears away heat and toxic materials, dredges blood and invigorates spirit; the rhubarb is bitter and cold in flavor, and has the effects of invigorating spleen, stomach, large intestine, liver and pericardium channels, purging heat and toxin, breaking food retention, removing blood stasis, clearing heat and purging fire, cooling blood and removing toxicity, and removing blood stasis and dredging the meridian, and the medicines are adjuvant medicines; the acanthopanax bark is sweet and slightly bitter in taste and pungent and warm in flavor, enters spleen, lung, heart and kidney channels, benefits qi and strengthens spleen, tonifies kidney and tranquilizes, strengthens muscles and bones, resists stress, is considered by modern pharmacology to have the effects of diminishing inflammation and easing pain, and is taken as a messenger drug, so that the pain can be relieved, and the healing of bone injury diseases can be accelerated.

Compared with the prior art, the invention has the advantages that: the medicine has reasonable compatibility, and has the functions of detumescence, stasis removal, blood circulation promotion, pain relief, reunion of fractured bones, hemostasis, pain relief and new tissue regeneration; the traditional Chinese medicine is mainly products of liver and kidney, supplements each other in the aspects of promoting blood circulation, enhancing tissue metabolism and strengthening fracture healing, has obvious efficacy, is suitable for closed fracture and comminuted fracture of various parts of the whole body, can obtain ideal curative effect without operation, and has obvious curative effect on osteoarthritis such as neck, shoulder, waist, leg, rheumatic ostealgia, traumatic injury and the like.

Detailed Description

The beneficial effects of the medicament of the invention are further illustrated by clinical efficacy observation experiments.

One, general data

Treating 300 patients with bone fracture, 200 men and 100 women with the age of 5-85 years;

II, diagnosis standard

Fracture, bone injury, cervical spondylosis, lumbar spondylosis, scapulohumeral periarthritis, synovitis, arthritis, rheumatism bone disease and traumatic injury, and has the symptoms of pain, limited function and the like, and X-ray film or CT film diagnosis is carried out;

third, therapeutic methods

The traditional Chinese medicine is ground into fine powder, can be prepared into pills or capsules, and is taken 9 g each time, three times a day, and 20 days is a course of treatment. The patients with mild symptoms are cured in one course of treatment, and the patients with severe symptoms are cured in 2 courses of treatment;

fourth, the evaluation criteria of curative effect

And (3) curing: after the medicine is taken for 1-2 courses of treatment, the bone injury has the advantages of 'muscle relaxing and qi smoothing, blood vessels smoothing', accelerating fracture healing and peripheral tissue repair, increasing blood circulation, promoting blood stasis absorption, causing bone cells to proliferate and denature, calcifying and ossify, and finally achieving the aims of bone connection, repairing cartilage, eliminating pain and recovering functions;

the effect is shown: after the medicine is taken, some related symptoms begin to be improved, such as pain is relieved, partial functions are recovered, and the life quality is improved;

and (4) invalidation: after the medicine is taken, all symptoms are not changed;

fifth, the therapeutic effect

294 cases are cured, 6 cases are obviously effective, 0 case is ineffective, and the total effective rate is 100%.

Claims

1. A traditional Chinese medicine for treating bone injury is characterized in that: the traditional Chinese medicine comprises the following components in parts by weight: 15 parts of dipsacus root, 10 parts of ground beetle, 10 parts of processed nux vomica, 15 parts of myrrh, 20 parts of safflower, 10 parts of dragon's blood, 10 parts of cinnabar, 20 parts of rhubarb and 30 parts of cortex acanthopanacis.